Brandon Michael Huffman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Pancreatic Ductal | 4 | 2024 | 1708 | 1.050 |
Why?
|
Pancreatic Neoplasms | 7 | 2024 | 5312 | 1.000 |
Why?
|
Anus Neoplasms | 2 | 2024 | 329 | 0.870 |
Why?
|
Adenocarcinoma | 5 | 2023 | 6312 | 0.820 |
Why?
|
Intestinal Neoplasms | 1 | 2019 | 311 | 0.550 |
Why?
|
Carcinoma, Papillary | 2 | 2019 | 785 | 0.540 |
Why?
|
Pancytopenia | 1 | 2017 | 101 | 0.530 |
Why?
|
Blood Cell Count | 1 | 2017 | 398 | 0.530 |
Why?
|
Esophageal Neoplasms | 2 | 2024 | 1655 | 0.520 |
Why?
|
Stomach Neoplasms | 2 | 2023 | 1422 | 0.520 |
Why?
|
Papillomavirus Infections | 2 | 2024 | 1601 | 0.500 |
Why?
|
Pancreas | 2 | 2019 | 1674 | 0.490 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2024 | 11656 | 0.470 |
Why?
|
Education, Medical | 2 | 2023 | 1726 | 0.470 |
Why?
|
Learning | 1 | 2023 | 1729 | 0.460 |
Why?
|
Intestine, Small | 1 | 2019 | 1204 | 0.420 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 4030 | 0.380 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9131 | 0.260 |
Why?
|
Immunotherapy | 2 | 2024 | 4626 | 0.230 |
Why?
|
Epithelial Cells | 1 | 2015 | 3664 | 0.210 |
Why?
|
Deoxycytidine | 2 | 2024 | 860 | 0.210 |
Why?
|
Mucin 5AC | 1 | 2023 | 97 | 0.210 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 155 | 0.190 |
Why?
|
Socialization | 1 | 2020 | 87 | 0.180 |
Why?
|
Exercise | 1 | 2017 | 5774 | 0.180 |
Why?
|
Internship and Residency | 1 | 2020 | 5860 | 0.180 |
Why?
|
Melanoma | 1 | 2018 | 5690 | 0.170 |
Why?
|
Paclitaxel | 2 | 2024 | 1716 | 0.160 |
Why?
|
Competency-Based Education | 1 | 2020 | 217 | 0.160 |
Why?
|
Interleukin-1beta | 1 | 2024 | 1000 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6530 | 0.150 |
Why?
|
Organoplatinum Compounds | 1 | 2019 | 409 | 0.150 |
Why?
|
Leucovorin | 1 | 2019 | 630 | 0.140 |
Why?
|
Pancreas Transplantation | 1 | 2018 | 196 | 0.140 |
Why?
|
Lymphocyte Count | 1 | 2019 | 776 | 0.140 |
Why?
|
Pancreatic Diseases | 1 | 2019 | 344 | 0.140 |
Why?
|
Feedback | 1 | 2020 | 791 | 0.140 |
Why?
|
Peritoneal Neoplasms | 1 | 2023 | 706 | 0.140 |
Why?
|
Iliac Artery | 1 | 2018 | 345 | 0.140 |
Why?
|
Aneurysm, False | 1 | 2018 | 259 | 0.130 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2011 | 0.120 |
Why?
|
Fluorouracil | 1 | 2019 | 1621 | 0.120 |
Why?
|
Histocytochemistry | 1 | 2015 | 693 | 0.120 |
Why?
|
Prognosis | 3 | 2019 | 29559 | 0.110 |
Why?
|
Humans | 20 | 2024 | 759098 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2925 | 0.110 |
Why?
|
Retrospective Studies | 5 | 2024 | 80125 | 0.110 |
Why?
|
Age Factors | 2 | 2019 | 18391 | 0.100 |
Why?
|
Cytosol | 1 | 2015 | 887 | 0.100 |
Why?
|
Mucins | 1 | 2015 | 569 | 0.100 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2018 | 1132 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3518 | 0.090 |
Why?
|
Aged | 7 | 2024 | 168615 | 0.090 |
Why?
|
Qualitative Research | 1 | 2020 | 2939 | 0.090 |
Why?
|
DNA | 1 | 2024 | 7235 | 0.090 |
Why?
|
Monocytes | 1 | 2019 | 2568 | 0.080 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58864 | 0.080 |
Why?
|
Middle Aged | 8 | 2024 | 219628 | 0.080 |
Why?
|
Observer Variation | 1 | 2015 | 2596 | 0.080 |
Why?
|
Male | 10 | 2024 | 358602 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2352 | 0.080 |
Why?
|
Disease Management | 1 | 2018 | 2495 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5637 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3569 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39213 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2911 | 0.070 |
Why?
|
Communication | 1 | 2020 | 3846 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2015 | 2912 | 0.070 |
Why?
|
Adult | 5 | 2023 | 219353 | 0.070 |
Why?
|
Neoplasms | 1 | 2015 | 22023 | 0.070 |
Why?
|
Biopsy | 1 | 2017 | 6770 | 0.060 |
Why?
|
Female | 8 | 2024 | 390174 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10515 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11125 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6853 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12793 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12526 | 0.060 |
Why?
|
Young Adult | 3 | 2019 | 58477 | 0.060 |
Why?
|
Cohort Studies | 2 | 2023 | 41266 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4583 | 0.050 |
Why?
|
Human papillomavirus 16 | 1 | 2024 | 266 | 0.050 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3812 | 0.050 |
Why?
|
Disease Progression | 1 | 2018 | 13470 | 0.050 |
Why?
|
Adolescent | 3 | 2019 | 87551 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13625 | 0.050 |
Why?
|
North America | 1 | 2024 | 1282 | 0.040 |
Why?
|
Social Identification | 1 | 2020 | 106 | 0.040 |
Why?
|
Gene Amplification | 1 | 2024 | 1085 | 0.040 |
Why?
|
Prospective Studies | 1 | 2024 | 54190 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2023 | 1744 | 0.040 |
Why?
|
DNA, Viral | 1 | 2024 | 2195 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20027 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 983 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4883 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2024 | 2524 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 24049 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2024 | 2810 | 0.030 |
Why?
|
DNA Repair | 1 | 2021 | 2039 | 0.020 |
Why?
|
Risk Factors | 1 | 2019 | 74167 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3616 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4523 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7593 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 29878 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5214 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 64867 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10181 | 0.020 |
Why?
|
Clinical Competence | 1 | 2020 | 4775 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3417 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9271 | 0.010 |
Why?
|
Mice | 1 | 2024 | 80993 | 0.010 |
Why?
|
Animals | 1 | 2024 | 167531 | 0.010 |
Why?
|